Recent Blog Posts

View Post: CIENCIASMEDICASNEWS: Medication Guides
15 hours ago by salud equitativa  
Intron A* (interferon alfa-2b) [2008 version] Kaletra (lopinavir and ritonavir) [2009 version] Keppra (levetiracetam) [2009 version] Ketek (telithromycin) [2007 version] Lamictal (lamotrigine) [2009 version] ...
View Blog: CIENCIASMEDICASNEWS - http://elbiruniblogspotcom.blogspot.com/

---

View Post: ODAC Recommends Approval of Pegylated Interferon Alfa-2b for ...
13 Oct 2009
The US Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for pegylated interferon alfa-2b (PegIntron) in the adjuvant treatment of patients with stage III ...
View Blog: Cancer Network - http://www.cancernetwork.com/

---

View Post: Chronic Hepatitis C Clinical Trial: Study Comparing Reduction and ...
8 Nov 2009
Interferon alfa-2b XL (IFN alfa-2b XL) is a novel sustained release interferon α-2b drug product that is being developed by FLAMEL TECHNOLOGIES using its Medusa® technology, aiming at reducing the toxicity and enhancing the biological ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Pegylated Interferon Alfa-2b Reduces Quality of Life in Stage III ...
29 Jul 2009 by mjames  
Although it improves recurrence-free survival, adjuvant (post-surgery) treatment with pegylated interferon alfa-2b adversely affects quality of life among patients with Stage III melanoma. These results were published in the Journal of ...
View Blog: CancerConsultants - http://www.cancerconsultants.com/

---

View Post: Orphan drug designation granted to TNFerade for pancreatic cancer ...
4 Nov 2009
INTRON A SOLN MULTIDOSE PENS. Neoplasms > Biological response modifiers. Interferon alfa-2b, recombinant; 18million IU, 30million IU, 60million IU; per pen; for SC inj; contains m-cresol. ...
View Blog: Latest articles from MPR - http://www.empr.com/

---

View Post: induction pegylated interferon alfa-2b in combination with ...
15 Sep 2009 by Brady DE, Torres DM, An JW, Davis M, Vemuri...  
the induction group received peg interferon alfa-2b 3.0 mcg/kg weekly for 12 weeks followed by peg interferon alfa-2b 1.5 mcg/kg weekly for 36 weeks and 13+/- 2 mg/kg ribavirin daily for 48 weeks. soc patients received peg interferon ...
View Blog: journalfeeds - http://journalfeeds.com/

---

View Post: Management of chronic hepatitis C patients who have relapsed or ...
8 Nov 2009 by JOC  
In the REPEAT trial, the sustained response rate was significantly higher in nonresponders to pegylated interferon alfa-2b (12 kD) plus ribavirin randomized to 72 weeks of peginterferon alfa-2a (40 kD) plus ribavirin, compared with a ...
View Blog: InfectoNews - Jorge Omar Calabrese - http://infectonews.wordpress.com/

---

View Post: U.S. FDA Issues Complete Response Letter Regarding PEGINTRON(R ...
2 Nov 2009
(NYSE: SGP - News) announced today the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON® (pegylated interferon alfa-2b) for the ...
View Blog: Latest articles from PMD - http://www.pmdcentral.com/

---

View Post: Cancer Journal: Latest cancer research Bevacizumab (Avastin) in ...
4 Sep 2009
A similar prolongation in PFS was reported in the 90206 trial with a median PFS of 8.4 versus 4.9 months for the bevacizumab-containing combination and the single agent interferon alfa-2b arms, respectively. An improvement in overall ...
View Blog: ecancer news - http://www.ecancermedicalscience.com/

---